Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…
Drug Manufacturers - General
US, Foster City [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Gilead Sciences, Inc. (GILD) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 43,500.19 | 5,206.20 | 691.40 | 4,046.86 | 126.36 | 0.01 | -6.6776 | 0.61 | 0.5457 | 0.0059 | 0.00 | 0.07 | 2.4063 | - - | ||
| Maximum | - - | - - | - - | 194,562.00 | 13,765.00 | 2,179.00 | 18,021.00 | 1,294.00 | 0.04 | 46.2856 | 2.71 | 0.7672 | 0.2203 | 0.03 | 0.53 | 21.1421 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 77.00 | -82.00 | -1,283.00 | -2,626.00 | 0.00 | -311.9276 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AstraZeneca PLC AZNCF | 125.50 | 1.70 1.37% | 0 vs. 1 | 194,562.00 | 12,622.00 | 2,179.00 | - - | - - | 1.4000 | - - | - - | 0.7521 | - - | - - | - - | - - | 1,550.00 | ||
| AbbVie Inc. ABBV | 171.73 | 3.97 2.37% | 5,621 vs. 5,440 | 303,470.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| Gilead Sciences, Inc. GILD | 89.76 | 1.13 1.28% | 3,896 vs. 6,733 | 111,865.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 58.23 | 0.35 0.60% | 6,131 vs. 11,052 | 118,100.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.13 | 0.19 0.76% | 44,697 vs. 36,462 | 142,411.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 289.90 | 2.03 0.71% | 3,283 vs. 2,169 | 155,830.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Eli Lilly and Company LLY | 749.92 | -3.49 -0.46% | 3,370 vs. 3,396 | 711,911.00 | 8,768.00 | 2,242.00 | 179.00 | 12,553.00 | 2.4900 | 76.3636 | 0.0017 | 0.8250 | 0.2558 | 0.1751 | 0.0351 | 0.6775 | 949.00 | ||
| Merck & Co., Inc. MRK | 99.86 | 2.42 2.48% | 12,019 vs. 9,695 | 252,609.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 155.50 | 2.39 1.56% | 6,508 vs. 6,343 | 374,384.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.